The radiotherapy company's novel SADA construct uses self-assembling tetramers to deliver isotopes directly to cancer cells for a highly targeted, less toxic treatment.
- Unlocking Business Value In Digital Health Solutions In Pharma
- Smart Drug Delivery Systems: Emerging Market Trends
- Oral Therapies Take Center Stage For PsO And PsA Treatment
- Design Controls For Drug Delivery Devices, Part 1: A Process Primer
- The Importance Of Primary And Secondary Drying And Their Impact On Lyophilization
- The Technologies Propelling GLP-1 Analogues
- Are CDMO Partnerships The Answer To Manufacturing Capacity Issues?
- Combination Products: U.S. Vs. EU Requirements And A Harmonized Strategy To Prepare CTD Module 3
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Vial Containment Systems For Gene And Cell Therapies
CZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
Meeting The Growing Demand For Pre-Filled Syringes
The market for pre-filled syringes is growing rapidly. Learn more about the benefits for consumers, providers, and manufacturers, and the importance of partnering with a reliable fill finish facility.
-
Considerations In Formulation Development Of Injectable Solutions
Injectable solutions offer an alternative to oral dosage form due to fast onset, reproducible PK/efficacy profile, high bioavailability, and suitability of administration under hospital setting.
-
Amorphous Formulations For Insoluble Drugs: Rational Design & Practical Approaches On Formulation Screening & Development
The issues associated with amorphous formulations include solid state stability, chemical stability, reproducibility of API manufacturing, impurity of API, in vitro in vivo performance, process and scale-up.
-
How A Flexible Approach To Autoinjector Assembly Can Be Advantageous
Examine how a flexible, scalable, and efficient solution for the assembly of autoinjectors can help you stay ahead of the competition and meet the demands of an ever-changing industry.
-
Partnership Goals For Scale-Up Success
As demand for capabilities and resources grows throughout a project, both become strained in-house and the scale-up process becomes a steeper hill to climb.
-
Improved Biomanufacturing Processes And Drug Product Stability
Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.
-
How Recent Trends Impact Bringing Your Molecule To Market
With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.
-
Mitigating Particulate Risk In Injectables
What are the sources of such particulates in injectables, and how should manufacturers apply the latest regulations to ensure best practice when producing sterile drug products?
-
Streamline Early-Stage Development To Reach The Clinic Faster
Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.
Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:
FRANKLY FRAN
-
In this article, Fran DeGrazio underscores the importance of design controls in the development of combination products and other drug delivery devices. She explains foundational concepts and fundamental steps including design inputs and outputs, design verification and validation, design review, and change controls.
- Subcutaneous Self-Administration: 3 Key Market Drivers, 3 Key Delivery Challenges
- Use-Related Risk Analysis: Considering The FDA Guidance On URRA
- Drug Delivery Outlook: 7 Waves To Ride In 2025 And Beyond
- 5 Top-Of-Mind Drug Delivery Topics In 2024
- Understanding Essential Drug Delivery Outputs: Things To Know About EDDOs
- 5 Keys to Supplier/Purchasing Controls – And Product Quality
- Preparing For The FDA QMSR: Will You Be Ready?
- Setting The Bar For Drug Product Quality, Part 2: The Evolving Practice Of Particle Testing
- Setting The Bar For Drug Product Quality, Part 1: How Best Practices Prevail